JASPER THERAPEUTICS, INC. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- JASPER THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2023-09-30 was $1.00K, a 50.00% decline year-over-year.
- JASPER THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2023-06-30 was $1.00K, a 50.00% decline year-over-year.
- JASPER THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2023-03-31 was $6.00K, a 100.00% increase year-over-year.
- JASPER THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2022-09-30 was $2.00K, a 33.33% decline year-over-year.
- JASPER THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for fiscal 2022 was $10.00K, a 0.00% change from fiscal 2021.
- JASPER THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for fiscal 2021 was $10.00K, a 0.00% change from fiscal 2020.
- JASPER THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for fiscal 2020 was $10.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.00K 10-Q · filed 2023-11-09 | |
| 2023-03-31 | $6.00K 10-Q · filed 2023-11-09 | |
| 2022-12-31 | $10.00K 10-K · filed 2023-03-08 | |
| 2022-09-30 | $2.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $2.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $3.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $10.00K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $3.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $2.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $3.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $10.00K 10-K · filed 2022-03-18 | |
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $3.00K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $2.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |